Marina Biotech Appoints Eric Teague as Chief Financial Officer
24 sept. 2018 08h00 HE
|
Marina Biotech, Inc.
Research Triangle Park, NC, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a commercial stage pharmaceutical company focused on the development and commercialization of...
Marina Biotech Announces a New Publication on Prestalia®
27 févr. 2018 10h15 HE
|
Marina Biotech, Inc.
City of Industry, CA, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics...
Marina Biotech Announces Agreement for Drug Development and Licensing with Autotelic Bio
16 janv. 2018 08h40 HE
|
Marina Biotech, Inc.
City of Industry, CA, Jan. 16, 2018 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics...
Marina Biotech Appoints Isaac Blech to its Board of Directors
27 nov. 2017 08h30 HE
|
Marina Biotech, Inc.
City of Industry, CA , Nov. 27, 2017 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics...